Daily FNArena News - FYI
All | Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure ChestPrevious Stories
Global Equity Gains Still On Track
Oct 30 2013
Russell Investments probes the global outlook for financial markets in 2014.
Is Market Sentiment Too Dovish?
Oct 30 2013
Forex.com’s Kathleen Brooks asks the obvious question.
Your Editor On Twitter
Oct 25 2013
This week’s Tweets on Twitter by Your Editor.
Stop Reading The AFR If You Are Scared!
Oct 23 2013
Peter Switzer of the Switzer Super Report defends investment in Australian banks against negativity in the press and elsewhere.
A Trader’s Wrap
Oct 21 2013
Chris Weston of IG markets discusses global financial market movements of the past 24 hours and his thoughts on the sessions ahead.
Your Editor On Twitter
Oct 18 2013
This week’s Tweets on Twitter by Your Editor.
Term Deposits Will Tell You When To Dump Stocks
Oct 16 2013
Peter Switzer of the Switzer Super Report suggests interest rates in Australia will have to return to normal before bank deposits again offer better value than stocks.
To Default, Or Not To Default …
Oct 16 2013
Forex.com’s Kathleen Brooks tries to inject some sanity into the drawn out saga that has become from the political stand-off in the US.
Extend And Pretend
Oct 15 2013
Saxo Bank believes a global slowdown is imminent as QE is not working, while Morgan Stanley remains positive on Australia from FY15.
Celldex Therapeutics – Too Late For Ted
Oct 11 2013
Life sciences sector analyst Stuart Roberts reports Celldex Therapeutics (Nasdaq: CLDX) is in Phase III with a cancer vaccine which can double median overall survival for glioblastoma patients.
